The prognosis prediction significance of Hounsfield unit value for stroke patients treated by intravenous thrombolysis
BMC Medical Imaging volume 21, Article number: 62 (2021)
Intravenous thrombolysis (IVT) is a rapid and effective treatment in the early stage of ischemic stroke patients and the purpose of this work is to explore the significance of Hounsfield unit (HU) value in Alberta Stroke Program Early CT Score (ASPECTS) for predicting the clinical prognosis of stroke patients with middle cerebral artery occlusion (MCAO) treated by IVT.
The 84 stroke patients with MCAO treated by IVT were divided into good prognosis group (48 cases) and poor prognosis group (36 cases). HU ratio and HU difference calculated from non-contrast computed tomography between groups were analyzed.
The HU ratio of good prognosis group was higher than that in poor prognosis group and the HU difference of good prognosis group was lower than that in poor prognosis group (P < 0.05). The HU ratio and ASPECTS were negatively correlated with the infarct volume, and the HU difference was positively correlated with the infarct volume (P < 0.05). HU difference was an independent risk factor for prognosis of patients with MCAO treated by IVT. The area under the receiver operating characteristic curve of HU ratio and HU difference for prognosis was 0.743 and 0.833 respectively.
The HU value changes are related to the clinical prognosis of stroke patients with MCAO treated by IVT, HU value may be a prognostic indicator for stroke patients with MCAO treated by IVT.
Intravenous thrombolysis (IVT) is a rapid and effective treatment in the early stage of ischemic stroke patients, which can restore blood flow, improve cerebral blood circulation, and improve the clinical prognosis of patients. However, the efficacy of IVT in different patients is significant different, and their clinical outcomes are different. Previous studies have shown that patients with higher Alberta Stroke Program Early CT Score (ASPECTS) usually have better clinical outcomes and a lower risk of symptomatic intracranial hemorrhage [1,2,3].
ASPECTS is a scoring method that can be used to evaluate early ischemic changes in the middle cerebral artery blood supply area. ASPECTS can be obtained on CT scan. This method is simple and easy to use, and is widely used by many stroke centers. However, stroke patients treated with IVT are in the hyperacute stage of stroke, and their head CT images change very slight, and the consistency and accuracy of ASPECTS are questioned due to subjective differences of observers .
The HU value reflects the water uptake of the infarcted tissue. As the water uptake increases, the HU value decreases. HU value can reflect the length of infarction time and can be used to judge the stroke time of the patients [4, 5]. Previous studies have shown that HU value from non-contrast computed tomography (NCCT) in ASPECTS helps to identify the core of infarction and is related to the final infarct volume of stroke after IVT [6, 7]. Therefore, this research aimed to explore the significance of HU value in ASPECTS for predicting the clinical prognosis of stroke patients with middle cerebral artery occlusion (MCAO) treated by IVT.
One hundred and forty stroke patients with MCAO in our hospital who received IVT from January 2018 to December 2019 were retrospectively analyzed. Inclusion criteria: ① age ≥ 18 years old; ② patients who arrived at the hospital within 6 h after stroke onset and received IVT; ③ stroke patient with MCAO was diagnosed by MRI images within 7 days after IVT; ④ complete patient clinical data. Exclusion criteria: ① poor CT image quality; ② patients with bilateral infarction. The last, 84 patients were included in the study and divided into good prognosis group (48 cases) and poor prognosis group (36 cases). This study was approved by the Research Ethics Committee of the Second Affiliated Hospital of Nantong University. The severity of stroke at admission was evaluated using National Institute of Health stroke scale (NIHSS). The clinical prognosis at 3 months after thrombolysis was evaluated using the modified Rankin Scale (mRS). According to mRS, the 84 stroke patients were divided into good prognosis group (0–2, 48 cases) and poor prognosis group (3–6, 36 cases). The clinical data of patients was showed in the Table 1.
Head scan was performed with Siemens FORCE CT (SOMATOM Force, Siemens Health Care, Germany). Scanning position: supine position; scanning positioning reference line: orbito-meatal line (OML); scanning parameter setting: tube voltage was 100 kV, tube current was 120 mA, and layer thickness was 2 mm. All patients underwent whole-brain MRI with the Siemens Verio 3.0 T MRI system (Magnetom Verio, Siemens Health Care, Germany). The scan settings for DWI using the SE echo-planar imaging (SE-EPI) sequence were as follows: TR = 6600 ms, TE = 100 ms, FA = 90°, FOV = 230 mm × 100 mm, matrix = 192 × 192, slice thickness = 5 mm, interslice gap = 1 mm, and b = 0, 1000 s/mm2.
Two radiologists with more than 5 years of neuroimaging diagnosis experience who were blinded to the clinical data measured the NCCT images. Ten separate regions corresponding to the standard middle cerebral artery territory ASPECTS areas were manually outlined. Both investigators defined ROIs limits individually and a consensus read was done to obtain definite ROIs limits that were used for further analysis (Fig. 1). The imaging software (Syngo.via VB20 workstation) calculated the radiological density of each ASPECT region using Hounsfield Units (HU). At least three measurements were carried out in each region and the mean HU values for each ASPECT region were recorded.
The HU value of 10 ASPECTS area of the infarct side cerebral hemisphere was divided by the HU value of the corresponding ASPECTS area of the healthy side cerebral hemisphere to obtain 10 HU ratios and the HU ratio of each patient was obtained by adding the ratio of each area. The HU value of 10 ASPECTS area in the infarcted side cerebral hemisphere was subtracted from the HU value of the corresponding ASPECTS area of the healthy hemisphere to obtain 10 HU differences and the HU difference of each patient was obtained by adding the difference of each area.
The HU values were built up as follows: (a) HU density of one ROI of an ASPECT region (Average of pixel values across ROI) ≥ ROI Mean value plus error, e.g. SD. (b) At least three measurements in each regions, i.e. 3 or more ROI values, and mean HU values for each region ≥ 3 * REGION Mean plus error * (ROI Mean + SD). (c) Adding the 10 HU difference values or ratio values of each area per patient to generate patient value. ≥ Sum((3*REGION 1 Mean plus error * (ROI Mean + SD)), (3*REGION 2 Mean plus error * (ROI Mean + SD)), …, (3*REGION 10 Mean plus error * (ROI Mean + SD))) = HU Difference or ratio per patient + error. The HU difference or ratio per patient without error was used subsequent research and analysis according to previous studies [7,8,9].
Patient with hemorrhagic transformation was defined as hemorrhage found on MRI images within 7 days after thrombolytic therapy. The patient's cerebral infarct volume was calculated on the DWI image within 7 days after thrombolytic therapy. The perimeter of the area of abnormal high-signal intensity was traced on each DWI image. The total lesion volume was calculated as the sum of the infarct area on each DWI slice × (slice thickness + interslice gap).The unit of infarct volume is ml .
Baseline NCCT image was used to grade the ASPECTS standardized 10-point scale by two stroke neurologist. Two raters achieved one common ASPECTS score per patient through consensus during a joint reading session.
The measurement data was expressed by mean ± SD or median, and the count data was expressed by percentage. The KS test was used to determine whether the data was normally distributed. The normal distribution data was analyzed with t test. Mann–Whitney U test was used to analyze non-normally distributed data. Spearman correlation analysis was used to evaluate the relationship between HU ratio/HU difference and infarct volume. The factors such as age, gender, initial NIHSS, ASPECTS, hyperdense middle cerebral artery sign (HMCAS), lenticular nucleus obscuration (LNO), HU ratio and HU difference were taken into the Binomial Logistic regression equation. The area under the ROC curve (AUC) was used to evaluate the diagnostic efficacy of ASPECTS, HU ratio and HU difference for the prognosis of stroke patients with MCAO treated by IVT. P value < 0.05 was considered statistically significant. All data were performed by SPSS 25.0 (IBM. Corp., Armonk, NY, USA) and MedCalc (MedCalc, Mariakerke, Belgium).
Comparison of clinical features between the two groups
The good prognosis group had lower admission NIHSS score than the poor prognosis group (median 7 vs 14) (P < 0.05), and higher ASPECTS than the poor prognosis group (median 10 vs 9) (P < 0.05). The good prognosis group had a smaller infarct volume than the poor prognosis group (median 3.61 vs 79.42) (P < 0.05). The good prognosis group has a lower risk of hemorrhagic transformation than the poor prognosis group (18.8% vs 44.4%) (P < 0.05). We found that the HU ratio and HU difference between the two groups were significantly different. The good prognosis group had a higher HU ratio than the poor prognosis group (9.97 ± 0.19 vs 9.75 ± 0.27) (P < 0.05), and a lower HU difference than the poor prognosis group (11.14 ± 2.44 vs 17.81 ± 7.61) (P < 0.05). In addition, our study also found that early image signs of NCCT (HMCAS and LNO) were associated with the prognosis of thrombolytic patients. The detailed results were shown in Table 1.
The relationship between HU ratio/HU difference/ ASPECTS and infarct volume
The HU ratio and ASPECTS were negatively correlated with the infarct volume, and the HU difference was positively correlated with the infarct volume (P < 0.05) (Fig. 2). The detailed results were shown in Table 2.
Independent risk factors for prognosis of stroke patients with MCAO treated by IVT
The factors such as age, gender, initial NIHSS, ASPECTS, HMCAS, LNO, HU ratio and HU difference were taken into the Binomial Logistic regression equation. The results showed the initial NIHSS and HU difference was independent risk factors for prognosis of stroke patients with MCAO treated by IVT (P < 0.05). The detailed results were shown in Table 3.
Diagnostic efficacy for the prognosis of stroke patients with MCAO treated by IVT
The ROC curve showed that AUC of ASPECTS, HU ratio, HU difference were 0.762, 0.743 and 0.833, which were meaningful to predict the prognosis of patients (P < 0.05). The AUC of the HU difference was greater than that of ASPECTS and HU ratio, but no statistical significance was found (P > 0.05) (Fig. 3). The detailed results were shown in Table 4.
Our research found that the changes in HU value of ASPECTS were related to the clinical prognosis of stroke patients with MCAO treated by IVT. HU difference was the independent risk factor for prognosis of stroke patients with MCAO treated by IVT. The changes in HU value can be used to predict the clinical prognosis of stroke patients with MCAO treated by IVT. HU value measurement can help clinicians make quick decisions and select potential beneficiaries of IVT.
Our research found that the HU ratio of the good prognosis group was higher than that of the poor prognosis group, and the HU difference was lower than that of the poor prognosis group. This may be because the decrease in HU value is significantly related to the increase in water content of ischemic brain tissue. It was reported that increasing the water content of the cerebral hemisphere by 1% will cause the HU value to decrease by 1.8 HU. Water uptake content of infarcted brain tissue was related to the degree of infarction [11, 12]. Our research found the HU ratio was negatively correlated with the infarct volume, and the HU difference was positively correlated with the infarct volume. Smaller HU ratio and larger HU difference were related to larger infarct volume. HU value is also related to the state of cerebral blood flow. Kucinski et al.  reported that within 4.5 h after the onset of stroke, the decrease in HU value was related to the decrease in cerebral blood flow and volume. In the hyperacute phase of stroke, the HU value changes very slightly. Compared with CTP and MRI, NCCT is difficult to accurately delineate the infarct range and measure the HU value. However, for stroke centers without advanced imaging techniques such as CTP and MRI, NCCT is still the preferred imaging examination before thrombolytic therapy. In order to overcome this difficulty, we selected 10 ASPECT regions to measure HU values in stroke patients with MCAO. For the hyperacute phase of stroke, NCCT can detect brain tissue swelling and gray matter lesions in time. NCCT has the advantages of fast imaging speed, low price and wide popularity. NCCT does not require contrast injection and will not cause adverse reactions. Our study also found that early image signs of NCCT (hyperdense middle cerebral artery sign, lenticular nucleus obscuration) were associated with the prognosis of thrombolytic patients, which is consistent with previous studies [14,15,16].
The ASPECTS is a scoring system for evaluating early ischemic changes in the blood supply area of the middle cerebral artery by NCCT. It is essentially based on visually low attenuation. In addition, the ASPECTS is time-dependent, and a study shown that the reliability of ASPECTS is moderate at stroke onset time < 90 min, good at 90–180 min, and excellent at > 180 min. The HU value is based on the attenuation coefficient of water to calculate the HU value of each tissue , which is quantitative in nature, and the measurement of HU value is independent of the subjective interpretation of any observer. Compared with the ASPECTS, the reliability and consistency of the HU value are greatly improved. In this study, two patients had the same ASPECTS, but their HU values changed differently, and their clinical outcomes were different (see Figs. 4, 5). The ROC curve showed that the AUC of the HU ratio was 0.743, when the cutoff value was 10, it had a higher sensitivity of 80.56%. The AUC of the HU difference was 0.833, when the cutoff value was 13.97, it had a higher specificity of 93.75%. The results indicated that the HU ratio and HU difference had important predictive value for the prognosis of stroke patients treated by IVT. For stroke patients with the same ASPECTS, the HU value can be used for a second evaluation to improve the accuracy of diagnosis. In the future, more research is needed to perfect this algorithm to improve the predictive value of HU. Our study has some limitations: ① The influence from the occlusion position on the patient was not taken into account, for stroke patients with a distant occlusion position, the infarct size was too small, and the HU value did not change significantly. ② Previous study shown that the weight of each area of ASPECTS was different . We did not weight each area when calculated the HU ratio or HU difference. ③ The sample size was small. ④ No subgroup analysis based on ASPECTS. ⑤ Ten ASPECTS regions were manually outlined and maybe there is an deviation. ⑥ The HU difference or ratio per patient without error used subsequent research and analysis may cause statistical error. In the future, we will adopt imageomics or deep learning methods to avoid it.
In summary, the HU value changes are related to the clinical prognosis of stroke patients with MCAO treated by IVT, HU value may be a prognostic indicator for stroke patients with MCAO treated by IVT.
Availability of data and materials
The datasets used during the current study are available from the corresponding author on reasonable request.
Alberta Stroke Program Early CT Score
Area under receiver operating characteristic curve
Hyperdense middle cerebral artery sign
Lenticular nucleus obscuration
Middle cerebral artery occlusion
Modified Rankin Scale
Non-contrast computed tomography
National Institute of Health stroke scale
Barber PA, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355(9216):1670–4.
Schroder J, Thomalla G. A critical review of Alberta Stroke Program Early CT Score for evaluation of acute stroke imaging. Front Neurol. 2016;7:245.
Tanaka K, et al. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis. J Thromb Thrombolysis. 2020;50(1):174–80.
Dzialowski I, et al. Ischemic brain tissue water content: CT monitoring during middle cerebral artery occlusion and reperfusion in rats. Radiology. 2007;243(3):720–6.
Minnerup J, et al. Computed tomography-based quantification of lesion water uptake identifies patients within 4.5 hours of stroke onset: a multicenter observational study. Ann Neurol. 2016;80(6):924–34.
Reidler P, et al. Attenuation changes in ASPECTS regions: a surrogate for CT perfusion-based ischemic core in acute ischemic stroke. Radiology. 2019;291(2):451–8.
Mokin M, et al. ASPECTS (Alberta Stroke Program Early CT Score) measurement using Hounsfield unit values when selecting patients for stroke thrombectomy. Stroke. 2017;48(6):1574–9.
Puig J, et al. Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2012;33(1):90–6.
Chavarria-Miranda A, et al. Quantified ischemic core’s radiological hypodensity and risk of parenchymal hematoma in > 4.5 h-window stroke thrombectomy. Sci Rep. 2020;10(1):16196.
Chen Z, et al. Upregulated serum MiR-146b serves as a biomarker for acute ischemic stroke. Cell Physiol Biochem. 2018;45(1):397–405.
Dzialowski I, et al. Brain tissue water uptake after middle cerebral artery occlusion assessed with CT. J Neuroimaging. 2004;14(1):42–8.
Zhao Q, et al. Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis—a retrospective analysis. Int J Clin Pharmacol Ther. 2017;55(12):893–900.
Kucinski T, et al. Cerebral perfusion impairment correlates with the decrease of CT density in acute ischaemic stroke. Neuroradiology. 2004;46(9):716–22.
Nedeltchev K, et al. Predictors of early mortality after acute ischaemic stroke. Swiss Med Wkly. 2010;140(17–18):254–9.
Sun H, et al. Intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign: a meta-analysis. Acta Neurol Scand. 2020;141(3):193–201.
Group, I.S.T.c., Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol. 2015;14(5):485–96.
Kalender WA. X-ray computed tomography. Phys Med Biol. 2006;51(13):R29-43.
Phan TG, et al. The ASPECTS template is weighted in favor of the striatocapsular region. Neuroimage. 2006;31(2):477–81.
This study was funded by the grant of Science Foundation of Nantong (MS12018087, MS12018042, HS2019002) and the grant of Science Foundation of Jiangsu Commission of Health (H2019057). The funding body was not involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Ethics approval and consent to participate
This study was approved by the Research Ethics Committee of the Second Affiliated Hospital of Nantong University. Due to the retrospective nature of the study, informed consent was waived.
Consent for publication
The consent for publication has been obtained from the patients.
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhu, Z., Zhang, R., Ren, K. et al. The prognosis prediction significance of Hounsfield unit value for stroke patients treated by intravenous thrombolysis. BMC Med Imaging 21, 62 (2021). https://doi.org/10.1186/s12880-021-00592-6